BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
48 results:

  • 1. Deep Learning Radiomics Nomogram Based on Multiphase Computed Tomography for Predicting Axillary Lymph Node Metastasis in Breast Cancer.
    Zhang J; Yin W; Yang L; Yao X
    Mol Imaging Biol; 2024 Feb; 26(1):90-100. PubMed ID: 37563517
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1
    Liu S; Huang C; Huang C; Huang Y; Yu Y; Wu G; Guo F; Jiang Y; Wan S; Zhu Z; Tian Y; Zhu J; Zhang J
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2227779. PubMed ID: 37349867
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
    Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
    Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular lymphoma.
    Ito M; Harada Y; Kagami Y; Hiraga J
    Intern Med; 2022; 61(14):2111-2116. PubMed ID: 35850985
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Functional investigation of chimeric antigen receptor T cells targeting LMP1 antigen].
    He HZ; Xing YY; Zhang Y; Xu YX; Tian Z; Xing HY; Tang KJ; Rao Q; Wang JX; Wang M
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):229-234. PubMed ID: 35405781
    [No Abstract]    [Full Text] [Related]  

  • 6. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic impact of maximum standardized uptake value on
    Qiu X; Liang H; Zhong W; Zhao J; Chen M; Zhu Z; Xu Y; Wang M
    Thorac Cancer; 2021 Mar; 12(6):845-853. PubMed ID: 33512768
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Using patient-specific bolus for pencil beam scanning proton treatment of periorbital disease.
    Kang M; Hasan S; Press RH; Yu F; Abdo M; Xiong W; Choi JI; Simone CB; Lin H
    J Appl Clin Med Phys; 2021 Jan; 22(1):203-209. PubMed ID: 33369041
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular lymphoma.
    Bararia D; Hildebrand JA; Stolz S; Haebe S; Alig S; Trevisani CP; Osorio-Barrios F; Bartoschek MD; Mentz M; Pastore A; Gaitzsch E; Heide M; Jurinovic V; Rautter K; Gunawardana J; Sabdia MB; Szczepanowski M; Richter J; Klapper W; Louissaint A; Ludwig C; Bultmann S; Leonhardt H; Eustermann S; Hopfner KP; Hiddemann W; von Bergwelt-Baildon M; Steidl C; Kridel R; Tobin JWD; Gandhi MK; Weinstock DM; Schmidt-Supprian M; Sárosi MB; Rudelius M; Passerini V; Mautner J; Weigert O
    Cell Rep; 2020 May; 31(5):107522. PubMed ID: 32330423
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
    [No Abstract]    [Full Text] [Related]  

  • 11. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.
    Zhu Y; He X; Lin YC; Dong H; Zhang L; Chen X; Wang Z; Shen Y; Li M; Wang H; Sun J; Nguyen LX; Zhang H; Jiang W; Yang Y; Chen J; Müschen M; Chen CW; Konopleva MY; Sun W; Jin J; Carlesso N; Marcucci G; Luo Y; Li L
    Blood; 2019 Oct; 134(15):1257-1268. PubMed ID: 31395602
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Different Types of
    He Y; Sheng W; Hu W; Lin J; Liu J; Yu B; Mao X; Zhang L; Huang J; Wang G
    Oncol Res; 2019 Aug; 27(8):901-910. PubMed ID: 30940295
    [No Abstract]    [Full Text] [Related]  

  • 13. CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome.
    Ou SI; Zhu VW
    Lung Cancer; 2019 Apr; 130():201-207. PubMed ID: 30885345
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature.
    Pelland-Marcotte MC; Hwee J; Pole JD; Nathan PC; Sung L
    Leuk Lymphoma; 2019 Sep; 60(9):2104-2114. PubMed ID: 30774019
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Meta-analysis of overall incidence and risk of ALK inhibitors-induced liver toxicities in advanced non-small-cell lung cancer.
    Li J; Yuan Z; Wang Q; Fan W; Zhang G
    Medicine (Baltimore); 2019 Jan; 98(1):e13726. PubMed ID: 30608384
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
    Redondo AM; Valcárcel D; González-Rodríguez AP; Suárez-Lledó M; Bello JL; Canales M; Gayoso J; Colorado M; Jarque I; Del Campo R; Arranz R; Terol MJ; Rifón JJ; Rodríguez MJ; Ramírez MJ; Castro N; Sánchez A; López-Jiménez J; Montes-Moreno S; Briones J; López A; Palomera L; López-Guillermo A; Caballero D; Martín A;
    Br J Haematol; 2019 Mar; 184(5):797-807. PubMed ID: 30548583
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High frequency of cd74 expression in lymphomas: implications for targeted therapy using a novel anti-cd74-drug conjugate.
    Zhao S; Molina A; Yu A; Hanson J; Cheung H; Li X; Natkunam Y
    J Pathol Clin Res; 2019 Jan; 5(1):12-24. PubMed ID: 30191677
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The combination of milatuzumab, a humanized anti-cd74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
    Christian BA; Poi M; Jones JA; Porcu P; Maddocks K; Flynn JM; Benson DM; Phelps MA; Wei L; Byrd JC; Wegener WA; Goldenberg DM; Baiocchi RA; Blum KA
    Br J Haematol; 2015 Jun; 169(5):701-10. PubMed ID: 25847298
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cd74 interferes with the expression of fas receptor on the surface of lymphoma cells.
    Berkova Z; Wang S; Ao X; Wise JF; Braun FK; Rezaeian AH; Sehgal L; Goldenberg DM; Samaniego F
    J Exp Clin Cancer Res; 2014 Oct; 33(1):80. PubMed ID: 25304249
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.